Edelson Lechtzin LLP has initiated an investigation into potential violations of federal securities laws involving Simulations Plus, Inc. (NASDAQ: SLP). The firm is examining allegations that the company may have provided misleading business information to investors. This inquiry comes in the wake of significant stock price declines following recent financial disclosures.
The firm is particularly interested in speaking with investors who suffered substantial losses and may possess non-public information pertinent to the investigation. Individuals can reach out directly to attorney Eric Lechtzin at Edelson Lechtzin LLP by calling 844-563-5550 ext. 1, or via email at [email protected].
Background of Simulations Plus, Inc.
Simulations Plus, Inc. specializes in software and consulting services designed to assist drug developers in modeling and optimizing the drug development process. The company has faced scrutiny after reporting weaker-than-anticipated results for the third quarter of 2025. On June 11, 2025, Simulations Plus announced these disappointing results, citing market and regulatory uncertainties as contributing factors. Following this announcement, the company’s stock price plummeted by $6.39 per share, translating to a decline of over 24%, closing at $20.05 per share on June 12, 2025.
The situation worsened for the company on July 14, 2025, when it disclosed a substantial $77.2 million charge related to prior acquisitions. Shortly thereafter, Simulations Plus terminated its relationship with Grant Thornton, citing unresolved reporting and internal control issues. Grant Thornton disputed this claim, stating that significant issues remained at the time of their dismissal. As a result of these developments, Simulations Plus’s stock fell an additional $4.50 per share, or 25.76%, closing at $12.97 on July 15, 2025.
About Edelson Lechtzin LLP
Edelson Lechtzin LLP operates as a national class action law firm with offices located in Newtown, Pennsylvania, and California. The firm specializes in various areas of law, including cases related to securities and investment fraud, antitrust violations, employee benefit plans, wage theft, consumer fraud, and issues surrounding dangerous or defective drugs and medical devices.
For more information or to participate in the investigation, interested parties can contact Marc H. Edelson or Eric Lechtzin at Edelson Lechtzin LLP. The firm’s contact details are as follows:
EDELSON LECHTZIN LLP
411 S. State Street, Suite N-300
Newtown, PA 18940
Phone: 844-696-7492 or 215-867-2399 ext. 1
Email: [email protected]
Email: [email protected]
Website: www.edelson-law.com
This press release may be considered attorney advertising in certain jurisdictions. No class has been certified in this case at this time, meaning that individuals are not represented by counsel unless they choose to retain one. Interested parties may select their own counsel or remain absent class members without any immediate action. Participation in any potential future recovery is not contingent upon serving as a lead plaintiff.
